{"id":820495,"date":"2025-03-03T08:34:25","date_gmt":"2025-03-03T13:34:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/"},"modified":"2025-03-03T08:34:25","modified_gmt":"2025-03-03T13:34:25","slug":"tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/","title":{"rendered":"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CHAPEL HILL, N.C., March  03, 2025  (GLOBE NEWSWIRE) &#8212; Tenax Therapeutics, Inc. (Nasdaq: TENX) (\u201cTenax Therapeutics\u201d or the \u201cCompany\u201d), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that the Company will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference, which is taking place from March 10-12, 2025, in Miami, FL.<\/p>\n<p>\n        <strong>Details of presentation:<\/strong>\n      <\/p>\n<p>\n        <strong>Format:<\/strong> Fireside Chat<\/p>\n<p>\n        <strong>Participants:<\/strong> Chris Giordano, President &amp; Chief Executive Officer, Stuart Rich, MD, Chief Medical Officer<\/p>\n<p>\n        <strong>Date and Time:<\/strong> March 10, 2025, at 3:40pm ET<\/p>\n<p>The live and archived webcast of the presentation will be accessible from the Company\u2019s investor relations\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cbaehm4_1H9VBZiS18l_Oddim5t8gJmYDZp-Jitt8aO61oSaW3DR5XdV0qylz75Of2w7PEpfODDtZYWxxjBCBmlZaqMUO6N2LgM97-j40PaDrYb6p4r5NG_iO0WHqNb7aReb_hk_j1EV0MUWmdafoQJAMHqQs6q_f9Dh4wC9J8JAjOxACUYDVSe13bvyaVOoOcj2tTLZdcmH1Ui__4XT6GeD8rcWx83ReLSw4imbAhQUPh1BskXsNzav1domXWPrI5iSdAS4l3zHqi98SEpWzA==\" rel=\"nofollow\" target=\"_blank\">webpage<\/a>.<\/p>\n<p>\n        <strong>About Tenax Therapeutics<\/strong>\n      <\/p>\n<p>Tenax Therapeutics, Inc. is a Phase 3, development-stage pharmaceutical company focused on developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company owns global rights to develop and commercialize levosimendan, which it has prioritized in the near term. Tenax Therapeutics also may resume developing its unique oral formulation of imatinib. For more information, visit www.tenaxthera.com. Tenax Therapeutics\u2019 common stock is listed on The Nasdaq Stock Market LLC under the symbol \u201cTENX\u201d.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Investor and Media:<\/p>\n<p>Merrill Barrett<br \/>Argot Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hSPiwaZjvcxqOAad76FT_U-aDaGw2-rOnqr7285aDrhsM7_2q-p-FHPodUanjQq83c_D40bLDTtP-atCPxscjasJFTZPrpUAIdl8kALSjz4=\" rel=\"nofollow\" target=\"_blank\">tenax@argotpartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmI0MjA0YjUtYWJiZC00Y2I4LTk4YjAtNzA2YThkYWU5MGY5LTEwMjE2MTQ=\/tiny\/Tenax-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHAPEL HILL, N.C., March 03, 2025 (GLOBE NEWSWIRE) &#8212; Tenax Therapeutics, Inc. (Nasdaq: TENX) (\u201cTenax Therapeutics\u201d or the \u201cCompany\u201d), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that the Company will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference, which is taking place from March 10-12, 2025, in Miami, FL. Details of presentation: Format: Fireside Chat Participants: Chris Giordano, President &amp; Chief Executive Officer, Stuart Rich, MD, Chief Medical Officer Date and Time: March 10, 2025, at 3:40pm ET The live and archived webcast of the presentation will be accessible from the Company\u2019s investor relations\u00a0webpage. About Tenax &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-820495","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHAPEL HILL, N.C., March 03, 2025 (GLOBE NEWSWIRE) &#8212; Tenax Therapeutics, Inc. (Nasdaq: TENX) (\u201cTenax Therapeutics\u201d or the \u201cCompany\u201d), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that the Company will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference, which is taking place from March 10-12, 2025, in Miami, FL. Details of presentation: Format: Fireside Chat Participants: Chris Giordano, President &amp; Chief Executive Officer, Stuart Rich, MD, Chief Medical Officer Date and Time: March 10, 2025, at 3:40pm ET The live and archived webcast of the presentation will be accessible from the Company\u2019s investor relations\u00a0webpage. About Tenax &hellip; Continue reading &quot;Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T13:34:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference\",\"datePublished\":\"2025-03-03T13:34:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/\"},\"wordCount\":217,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/\",\"name\":\"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=\",\"datePublished\":\"2025-03-03T13:34:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - Market Newsdesk","og_description":"CHAPEL HILL, N.C., March 03, 2025 (GLOBE NEWSWIRE) &#8212; Tenax Therapeutics, Inc. (Nasdaq: TENX) (\u201cTenax Therapeutics\u201d or the \u201cCompany\u201d), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that the Company will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference, which is taking place from March 10-12, 2025, in Miami, FL. Details of presentation: Format: Fireside Chat Participants: Chris Giordano, President &amp; Chief Executive Officer, Stuart Rich, MD, Chief Medical Officer Date and Time: March 10, 2025, at 3:40pm ET The live and archived webcast of the presentation will be accessible from the Company\u2019s investor relations\u00a0webpage. About Tenax &hellip; Continue reading \"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-03T13:34:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference","datePublished":"2025-03-03T13:34:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/"},"wordCount":217,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/","name":"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=","datePublished":"2025-03-03T13:34:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NzEzNyM2Nzg0OTc1IzIwMTAwNDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenax-therapeutics-to-participate-in-the-leerink-partners-2025-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=820495"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820495\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=820495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=820495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=820495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}